Crossmark

Ivermectin’s neuroprotective effects decrease with prolonged use after cerebral ischemia/reperfusion

Published Online: 2025-06-25

Authors

Rezaei, Sevda

Babataheri, Shabnam

Soraya, Hamid https://orcid.org/0000-0003-0602-230X
License Information

Text and Data Mining valid from 2025-06-25

Version of Record valid from 2025-06-25
More Information

Article History

Received: 22 February 2025

Accepted: 10 June 2025

First Online: 25 June 2025

Declarations

:

: The study was approved by the Ethics Committee of Urmia University of Medical Sciences, with a decision dated 12.07.2023, and ethics code IR.UMSU.AEC.1402.006.

: The authors declare no competing interests.

Document is current